english.prescrire.org > Spotlight > Archives : 2021 > Covid-19: a recap of treatment options. From Prescrire's comprehensive year-end review

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2021 : 1 | 30 | 60

Covid-19: a recap of treatment options. From Prescrire's comprehensive year-end review

FEATURED REVIEW Very large amounts of data about covid-19 were published over the past year. As they became available, Prescrire sorted through to determine just which data were useful for the treatment and prevention of the disease.
Full review (3 pages) available for download by subscribers.

Abstract

  • In order to provide high-quality health care, it is useful to continually reassess which products to use and those to avoid, recognising the difference between a therapeutic advance and a new product that serves only commercial interests, and between false, biased or worthless information and robust, proven, practical information.
     
  • 2020 was marked by the covid-19 pandemic, a disease caused by infection with the coronavirus Sars-CoV-2.
     
  • Little was known about this infection when it first emerged in the winter of 2019-2020, but very large amounts of data were published about it in 2020.
     
  • Prescrire sorted through them as they became available, in order to determine which data were useful for the treatment and prevention of covid-19.

©Prescrire 1 March 2021

Source: "Covid-19: a recap of treatment options. From Prescrire's comprehensive year-end review" Prescrire International 2021; 30 (224): 73-75. Subscribers only.

Enjoy full access to Prescrire International, and support independent information
Share
Share on Facebook Share on Twitter


For more information:

  COVID-19 
Follow Prescrire's
independent, evidence-based
analysis of the pandemic 
Free


Read more:

All the subjects in
Prescrire's Spotlight
Free >